tirzepatide vs semaglutide weight loss studies versus Once Weekly in Patients with Type 2 Diabetes Clinical trials of subcutaneous tirzepatide

Do not use in children under 18 years of age

Researchers altered the amino acid sequence and attached a fatty acid chain so the molecule survives longer in circulation

If you notice that your side effect timing shifts when you change injection sites, absorption variability is likely the explanation

These features make them suitable for elderly patients, those with impaired renal function, and individuals intolerant to other glucose-lowering agents

10.1016/j.neurobiolaging.2016.08.019 Neurobiol

Attention deficit disorder (ADD) was assessed by the question Has a doctor or health professional ever told you that you had ADD? (yes/no) [20]